Immunomic Therapeutics, Inc. to Present at Skin Vaccination Summit in Switzerland
August 28, 2015 08:30 ET
|
Immunomic Therapeutics, Inc.
HERSHEY, Pa. and ROCKVILLE, Md., Aug. 28, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing vaccines based on its proprietary LAMP...
Immunomic Therapeutics, Inc. Taps Micronaut to Visually Demonstrate Its LAMP-vax Programs
June 16, 2015 12:18 ET
|
Immunomic Therapeutics, Inc.
HERSHEY, Pa. and ROCKVILLE, Md., June 16, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing vaccines based on its proprietary LAMP...
Immunomic Therapeutics, Inc. CEO, William Hearl, Ph.D. to Speak at 2015 BIO International Convention
June 03, 2015 09:35 ET
|
Immunomic Therapeutics, Inc.
HERSHEY, Pa. and ROCKVILLE, Md., June 3, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing vaccines based on its proprietary LAMP...
Immunomic Therapeutics, Inc. Awarded $1.2M Department of Defense Grant for Development of ARA-LAMP-vax Peanut Allergy Vaccine
May 13, 2015 09:35 ET
|
Immunomic Therapeutics, Inc.
HERSHEY, Pa. and ROCKVILLE, Md., May 13, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing vaccines based on its proprietary LAMP...
Immunomic Therapeutics Names Louise Peltier as Vice President, Regulatory Affairs
May 06, 2015 09:45 ET
|
Immunomic Therapeutics, Inc.
HERSHEY, Pa. and ROCKVILLE, Md., May 6, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc., ("ITI") a privately-held biotechnology company developing vaccines based on its proprietary LAMP...
Immunomic Therapeutics Appoints Eric Winzer as Chief Financial Officer
May 04, 2015 11:06 ET
|
Immunomic Therapeutics, Inc.
HERSHEY, Pa. and ROCKVILLE, Md., May 4, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. (ITI), a privately-held biotechnology company developing vaccines based on its proprietary LAMP...
Immunomic Therapeutics to Present at 15th Annual World Vaccine Congress
April 02, 2015 09:45 ET
|
Immunomic Therapeutics, Inc.
HERSHEY, Pa. and ROCKVILLE, Md., April 2, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc., ("ITI") a privately-held biotechnology company pioneering next-generation vaccines based on its...
Immunomic Therapeutics, Inc. Awarded SBIR Grant From NIH for Nanoplasmid Peanut Allergy Vaccine Development
March 31, 2015 09:40 ET
|
Immunomic Therapeutics, Inc.
HERSHEY, Pa. and ROCKVILLE, Md., March 31, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing vaccines based on its proprietary LAMP...
Immunomic Therapeutics Receives Positive Feedback From FDA Following Pre-IND Discussions for Its Proprietary Peanut Allergy Vaccine
March 25, 2015 12:26 ET
|
Immunomic Therapeutics, Inc.
HERSHEY, Pa., and ROCKVILLE, Md., March 25, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc., ("ITI") a privately-held biotechnology company developing vaccines based on its proprietary LAMP...
Immunomic Therapeutics to Present at BIO-Europe Annual Conference
March 09, 2015 07:00 ET
|
Immunomic Therapeutics, Inc.
HERSHEY, Pa. and ROCKVILLE, Md., March 9, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc., ("ITI") a privately-held biotechnology company developing vaccines based on its proprietary LAMP...